Ad hoc announcement pursuant to Art. 53 LRRelfydessTM (RelabotulinumtoxinA) is the first and only ready-to-use liquid neuromodulator created with PEARLTM Technology, developed and manufactured by Galderma1,2This positive decision is based o
东京、宾夕法尼亚州马尔文、比利时根特--(美国商业资讯)-- H.U. Group Holdings Inc.及其全资子公司Fujirebio今天宣布推出Lumipulse G GFAP检测试剂盒,用于该公司的全自动随机存取LUMIPULSE G免疫系统分析系统。研究专用(RUO)检测试剂盒现已在美国上市,并